Resumen: Introducción: La cardioplejia Custodiol® ofrece protección miocárdica durante tres horas mediante dosis única permitiendo realizar procedimientos complejos sin interrupción.
Delfina Fletcher-Sanfeliu +9 more
exaly +3 more sources
Modified Del Nido Versus Custodiol® Cardioplegia for Myocardial Protection in Adult Patients Undergoing Cardiac Surgery; A Prospective Randomized Double-Blinded Clinical Trial [PDF]
Background: Cardioplegia is essential for myocardial protection. Modified Del Nido and Custodiol® cardioplegia have been successfully used; however, a limited number of clinical trials compared both solutions.
Mahdy A. Abdelhady +4 more
doaj +2 more sources
Blood cardioplegia or custodiol for myocardial protection during valvular or aortic surgery: a propensity score adjusted comparison [PDF]
Background There is no solid evidence on the clinical benefits of blood cardioplegia or Custodiol™ in procedures other than coronary artery bypass grafting.
Manuel Carnero- Alcazar +9 more
doaj +2 more sources
Myocardial protection during surgery for infective endocarditis: retrospective, single center, risk-adjusted study [PDF]
Objectives Current evidence does not support superiority of one cardioplegia type over another, but stems from low-risk populations. Therefore, we compared outcomes of multimorbid, high-risk infective endocarditis (IE) patients receiving Custodiol ...
Murat Mukharyamov +13 more
doaj +2 more sources
Cardioplegia Strategies in Minimally Invasive Aortic Valve Replacement: An Inverse Probability of Treatment Weighting Analysis [PDF]
Background and Objectives: Optimal myocardial protection during minimally invasive aortic valve replacement (MIAVR) is debated. We compared four cardioplegia strategies.
Lukman Amanov +12 more
doaj +2 more sources
A Systematic Review of Renal Perfusion in Complex Abdominal Aortic Aneurysm Open Repair [PDF]
Introduction: This systematic review aims to analyze the current literature regarding 30-day mortality and postoperative acute kidney disease (AKI) in complex abdominal aortic aneurysms (cAAAs), which included juxtarenal aortic aneurysm (JAA), suprarenal
Diletta Loschi +5 more
doaj +2 more sources
How different cardioplegic solutions influence genes expression and cytokine response in an immature rat heart model of ischemia/reperfusion? [PDF]
IntroductionThe use of cardioplegia not only achieves cardiac arrest but also minimizes ischemic/reperfusion (I/R) injury, potentially improving short- or long-term outcomes.
Arslan Mamedov +9 more
doaj +2 more sources
Custodiol versus Blood Cardioplegia: Comparison of Myocardial Immunohistochemical Analysis and Clinical Outcomes [PDF]
Introduction: Custodiol (histidine-tryptophan-ketoglutarate) and repetitive blood cardioplegia are the solutions for myocardial protection and cardiac arrest. In this study, we aimed to compare immunohistochemical analysis, clinical outcomes, and cardiac
Onur Sen +8 more
doaj +1 more source
Comparison of Custodiol® and modified St. Thomas cardioplegia for myocardial protection in coronary artery bypass grafting [PDF]
Background/Aim. Custodiol® is a hyperpolarizing cardioplegic solution which has been used in our national cardiac surgical practice exclusively for the heart transplant surgery.
Cvetković Dragan +12 more
doaj +1 more source
Background: Histidine-tryptophan-ketoglutarate (HTK), Bretschneider’s, or Custodiol is an intracellular crystalloid cardioplegic solution which is claimed to offer single shot cardioplegia for myocardial protection during complex cardiac procedures for ...
Walaa Ahmed Saber +4 more
doaj +1 more source

